Disclosure Of Interests In Other Entities [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166293

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
- EUR
Current assets
53,959 EUR
66,613 EUR
Non-current assets
9,485 EUR
2,569 EUR
Current liabilities
14,978 EUR
2,132 EUR
Non-current liabilities
409,000 EUR
7,991 EUR
Revenue
3,096 EUR
175,000 EUR
Profit (loss)
11,579 EUR
7,145 EUR
Comprehensive income
- EUR
- EUR
- EUR
- EUR
11,579 EUR
11,579 EUR
7,145 EUR
- EUR
7,145 EUR
- EUR
- EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
- EUR
- EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
50,012 EUR
64,399 EUR
205,000 EUR
Other current financial liabilities
11,815 EUR
409,000 EUR
Other non-current financial liabilities
300,000 EUR
7,885 EUR
Tax expense (income)
297,000 EUR
1,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.